Osman Yokus1, Erdem Sunger2, Tahir Alper Cinli1, Hasan Goze1, Istemi Serin1. 1. University of Health Sciences, Istanbul Training and Research Hospital, Department of Hematology Istanbul, Turkey. 2. University of Health Sciences, Bagcilar Training and Research Hospital, Department of Internal Medicine Istanbul, Turkey.
Abstract
BACKGROUND: Low albumin and high ferritin levels have negative effects on survival in acute myeloid leukemia (AML). In this study, the aim is to determine the role of these factors on survival in patients over 50 years of age with AML. METHODS: Eighty patients followed up between January 2014 and July 2019 were included in the study. Patients were categorised into three subgroups: The favorable, intermediate and high-risk groups. RESULTS: The overall survival of the favorable group was found to be longer in a statistically significant way. CONCLUSION: In this study, it has been shown that serum albumin and ferritin values are useful and simple laboratory values to show prognosis in AML over 50 years of age. AJBR
BACKGROUND: Low albumin and high ferritin levels have negative effects on survival in acute myeloid leukemia (AML). In this study, the aim is to determine the role of these factors on survival in patients over 50 years of age with AML. METHODS: Eighty patients followed up between January 2014 and July 2019 were included in the study. Patients were categorised into three subgroups: The favorable, intermediate and high-risk groups. RESULTS: The overall survival of the favorable group was found to be longer in a statistically significant way. CONCLUSION: In this study, it has been shown that serum albumin and ferritin values are useful and simple laboratory values to show prognosis in AML over 50 years of age. AJBR
Authors: Andrew S Artz; Brent Logan; Xiaochun Zhu; Gorgun Akpek; Rodrigo Martino Bufarull; Vikas Gupta; Hillard M Lazarus; Mark Litzow; Alison Loren; Navneet S Majhail; Richard T Maziarz; Philip McCarthy; Uday Popat; Wael Saber; Stephen Spellman; Olle Ringden; Amittha Wickrema; Marcelo C Pasquini; Kenneth R Cooke Journal: Haematologica Date: 2016-08-04 Impact factor: 9.941
Authors: Hartmut Döhner; Elihu Estey; David Grimwade; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Hervé Dombret; Benjamin L Ebert; Pierre Fenaux; Richard A Larson; Ross L Levine; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel Sanz; Jorge Sierra; Martin S Tallman; Hwei-Fang Tien; Andrew H Wei; Bob Löwenberg; Clara D Bloomfield Journal: Blood Date: 2016-11-28 Impact factor: 22.113